Dengue: an update.

[1]  R. He,et al.  Antibody-enhanced binding of dengue-2 virus to human platelets. , 1995, Virology.

[2]  S. Halstead.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. , 1970, The Yale journal of biology and medicine.

[3]  J. Mascola,et al.  Human skin Langerhans cells are targets of dengue virus infection , 2000, Nature Medicine.

[4]  M. Guzmán,et al.  Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. , 1995, The American journal of tropical medicine and hygiene.

[5]  R. Gur,et al.  Evaluation of three commercially available kits for serological diagnosis of dengue haemorrhagic fever. , 2000, Diagnostic microbiology and infectious disease.

[6]  P. Glaziou,et al.  Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. , 1994, The Journal of infectious diseases.

[7]  S. Halstead.  Is there an inapparent dengue explosion? , 1999, The Lancet.

[8]  I. Kurane,et al.  Development of dengue IgM-capture enzyme-linked immunosorbent assay with higher sensitivity using monoclonal detection antibody. , 2001, Journal of virological methods.

[9]  K. Porter,et al.  Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques. , 2000, The Journal of general virology.

[10]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[11]  N. Bhamarapravati,et al.  Live attenuated tetravalent dengue vaccine. , 2000, Vaccine.

[12]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.

[13]  M. Guzmán,et al.  Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  N. M. Dung,et al.  Neurological manifestations of dengue infection , 2000, The Lancet.

[15]  S. Halstead,et al.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever , 1999, The Lancet.

[16]  S. Halstead,et al.  Epidemiologic studies on Dengue in Santiago de Cuba, 1997. , 2000, American journal of epidemiology.

[17]  K. Morita,et al.  Rapid detection of virus genome from imported dengue fever and dengue hemorrhagie fever patients by direct polymerase chain reaction , 1994, Journal of medical virology.

[18]  G. Kuno,et al.  Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. , 1985, Bulletin of the World Health Organization.

[19]  S. Kalayanarooj,et al.  A study of erythrocyte sedimentation rate in dengue hemorrhagic fever. , 1989, The Southeast Asian journal of tropical medicine and public health.

[20]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[21]  N. M. Dung,et al.  Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[22]  E. Harris,et al.  Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. , 1999, The American journal of tropical medicine and hygiene.

[23]  T. Monath,et al.  Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. , 1997, Vaccine.

[24]  A. Mazzei.  Molecular biology of dengue virus , 1998 .

[25]  R. Rico-Hesse,et al.  Dengue Virus Structural Differences That Correlate with Pathogenesis , 1999, Journal of Virology.

[26]  M. Guzmán,et al.  Fatal dengue hemorrhagic fever in Cuba, 1997. , 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[27]  M. Guzmán,et al.  Study of biologic attributes of Cuban dengue 2 virus after serial passage in primary dog kidney cells. , 2001, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  F. Ennis,et al.  Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. , 1998, Virology.

[29]  F. Ennis,et al.  Human Dendritic Cells Are Activated by Dengue Virus Infection: Enhancement by Gamma Interferon and Implications for Disease Pathogenesis , 2001, Journal of Virology.

[30]  H. Gómez-Dantés,et al.  Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. , 1996, Emerging infectious diseases.

[31]  M. Guzmán,et al.  Comparison of Rapid Centrifugation Assay with Conventional Tissue Culture Method for Isolation of Dengue 2 Virus in C6/36-HT Cells , 2000, Journal of Clinical Microbiology.

[32]  F. Pinheiro,et al.  Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. , 1997, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[33]  F. Ennis,et al.  Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever , 1994 .

[34]  G. Crane.  Dengue haemorrhagic fever: diagnosis, treatment, prevention and control , 1999 .

[35]  R. Dhawan,et al.  Dengue virus‐induced human cytotoxic factor: production by peripheral blood leucocytes in vitro , 1995, Clinical and experimental immunology.

[36]  P. Reiter.  Global warming and mosquito-borne disease in USA , 1996, The Lancet.

[37]  F. Ennis,et al.  Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells , 1988, Journal of virology.

[38]  A. Issekutz,et al.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes , 1997, Journal of virology.

[39]  S. Halstead,et al.  Disease severity‐related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies , 1987, Journal of medical virology.

[40]  P. Young,et al.  An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients , 2000, Journal of Clinical Microbiology.

[41]  C. Leslie.  Life in the 21st Century. , 1982 .

[42]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[43]  Robert Anderson,et al.  Release of Vasoactive Cytokines by Antibody-Enhanced Dengue Virus Infection of a Human Mast Cell/Basophil Line , 2000, Journal of Virology.

[44]  J. Rigau-Pérez.  Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists. , 1997, Revista panamericana de salud publica = Pan American journal of public health.

[45]  D. Shroyer,et al.  Comparative susceptibility of five species of Toxorhynchites mosquitoes to parenteral infection with dengue and other flaviviruses. , 1985, The American journal of tropical medicine and hygiene.

[46]  X. de Lamballerie,et al.  Complete genomic sequence of a dengue type 2 virus from the French West Indies. , 2000, Biochemical and biophysical research communications.

[47]  A. Nisalak,et al.  Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription‐polymerase chain reaction , 2001, Journal of medical virology.

[48]  A. Rothman,et al.  Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting Serotype , 1999, Journal of Virology.

[49]  E. Holmes,et al.  Widespread intra-serotype recombination in natural populations of dengue virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Guzmán,et al.  Molecular epidemiology of dengue-1 and dengue-4 viruses. , 1995, The Journal of general virology.

[51]  M. Guzmán,et al.  Advances in dengue diagnosis , 1996, Clinical and diagnostic laboratory immunology.

[52]  Hammon Wm.  Dengue hemorrhagic fever--do we know its cause? , 1973 .

[53]  Jones Js,et al.  Life in the 21st century - a vision for all. , 1998 .

[54]  D. Gubler,et al.  Dengue and dengue haemorrhagic fever , 1998, The Lancet.

[55]  K. Porter,et al.  Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells. , 1997, The Journal of general virology.

[56]  A. Nisalak,et al.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.

[57]  Benjamin Rush.  Medical inquiries and observations , 1805 .

[58]  Yee‐Shin Lin,et al.  Generation of IgM anti‐platelet autoantibody in dengue patients , 2001, Journal of medical virology.

[59]  L. Rosen,et al.  Disease exacerbation caused by sequential dengue infections: myth or reality? , 1989, Reviews of infectious diseases.

[60]  M. Guzmán,et al.  Reacción en cadena de la polimerasa para la detección rápida y determinación del serotipo de virus del dengue en muestras clínicas , 1998 .

[61]  N. Karabatsos,et al.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.

[62]  Bravo González,et al.  La emergencia de la fiebre hemorrágica del dengue en las Américas. Reemergencia del dengue , 1999 .

[63]  E. Holmes,et al.  The causes and consequences of genetic variation in dengue virus. , 2000, Trends in microbiology.

[64]  R. Rico-Hesse,et al.  Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.

[65]  K. Russell,et al.  A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys. , 2000, Vaccine.

[66]  B. Seliger,et al.  Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.

[67]  C. Ramos,et al.  Dengue virus (serotype 3) circulation in endemic countries and its reappearance in America. , 2000, Archives of medical research.

[68]  R. Lanciotti,et al.  Molecular evolution and phylogeny of dengue-4 viruses. , 1997, The Journal of general virology.

[69]  M. C. Williams,et al.  Dengue in the Caribbean: virus isolation in a mosquito (Aedes pseudoscutellaris) cell line. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[70]  Benjamin Rush.  An account of the bilious remitting fever: As it appeared in philadelphia, in the summer and autumn of the year 1780 , 1951 .

[71]  S. Halstead,et al.  Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.

[72]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[73]  Laura D. Kramer,et al.  Typing of Dengue Viruses in Clinical Specimens and Mosquitoes by Single-Tube Multiplex Reverse Transcriptase PCR , 1998, Journal of Clinical Microbiology.

[74]  D. Gubler,et al.  Viraemia in patients with naturally acquired dengue infection. , 1981, Bulletin of the World Health Organization.

[75]  H. Schatzmayr,et al.  Fatal primary dengue infections in Brazil. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[76]  M. Guzmán,et al.  Normalización de técnicas inmunohistoquímicas para la detección de antígenos del virus dengue en tejidos embebidos en parafina , 1997 .

[77]  M. Guzmán,et al.  Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. , 1990, The American journal of tropical medicine and hygiene.

[78]  D. Morens,et al.  Antibody-dependent enhancement of infection and the pathogenesis of viral disease. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  G. Kourí,et al.  Enfermedades virales emergentes , 2001 .

[80]  G. Kuno,et al.  An ELISA procedure for the diagnosis of dengue infections. , 1991, Journal of virological methods.

[81]  D. Gubler.  Surveillance for dengue and dengue hemorrhagic fever. , 1989, Bulletin of the Pan American Health Organization.

[82]  H. Schatzmayr,et al.  Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[83]  P. Thongcharoen.  Monograph on dengue/dengue haemorrhagic fever , 1993 .

[84]  S. Nimmannitya,et al.  Clinical spectrum and management of dengue haemorrhagic fever. , 1987, The Southeast Asian journal of tropical medicine and public health.

[85]  T. Jelínek,et al.  Influence of Rheumatoid Factor on the Specificity of a Rapid Immunochromatographic Test for Diagnosing Dengue Infection , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[86]  B. Pandey,et al.  Severity‐Related Molecular Differences among Nineteen Strains of Dengue Type 2 Viruses , 2000, Microbiology and immunology.

[87]  M. Guzmán,et al.  Detection and genetic relationship of dengue virus sequences in seventeen-year-old paraffin-embedded samples from Cuba. , 1999, The American journal of tropical medicine and hygiene.

[88]  D. Gubler,et al.  Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. , 1983, Bulletin of the World Health Organization.

[89]  M. Seguin,et al.  Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. , 1983, The American journal of tropical medicine and hygiene.

[90]  S. Halstead,et al.  Do escape mutants explain rapid increases in dengue casefatality rates within epidemics? , 2000, The Lancet.

[91]  M. Guzmán,et al.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.

[92]  R. Nogueira,et al.  Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[93]  D. Ha,et al.  Tumor necrosis factor alpha levels in plasma and whole‐blood culture in dengue‐infected patients: Relationship between virus detection and pre‐existing specific antibodies , 1998, Journal of medical virology.

[94]  P. Farmer,et al.  Social inequalities and emerging infectious diseases. , 1996, Emerging infectious diseases.

[95]  F. Guirakhoo,et al.  Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates , 2000, Journal of Virology.

[96]  E. Chungue,et al.  Rapid and sensitive streptavidin‐biotin amplified fluorogenic enzyme‐linked immunosorbent‐assay for direct detection and identification of dengue viral antigens in serum , 1995, Journal of medical virology.

[97]  D. Gubler,et al.  A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. , 1976, The American journal of tropical medicine and hygiene.

[98]  M. Shaio,et al.  Production of cytokines and platelet activating factor in secondary dengue virus infections. , 1995, The Journal of infectious diseases.

[99]  M. Cunningham,et al.  Effects of Microbes on the Immune System , 2000 .

[100]  A. Nisalak,et al.  Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. , 1999, The Journal of infectious diseases.